1. Home
  2. OGEN

OGEN

Oragenics Inc.

Logo Oragenics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Founded: 1996 Country:
United States
United States
Employees: N/A City: SARASOTA
Market Cap: 4.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 99.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -9.18 EPS Growth: N/A
52 Week Low/High: $1.16 - $7.74 Next Earning Date: 05-10-2024
Revenue: $37,653 Revenue Growth: -71.37%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: